Trialect

Active

Notice of Special Interest (NOSI): Leveraging Data Science to Bring Actionable Insights for Substance Use Prevention and Treatment

National Institutes of Health

This Notice encourages research projects that 1) leverage data science to provide actionable insights for substance use prevention and treatment, 2) shorten the time between data capture and data availability so that data are available real-time or near real-time, and 3) explore methods and tools that may allow for faster or better localized responses for substance use treatment and prevention. Priority will be given to projects that emphasize the use of existing data streams (e.g., electronic health records, syndromic surveillance, claims data, registry data, pharmacy dispensing, social media, and mortality records).

Collaborations among multiple disciplines are encouraged for this Notice. Priority will be given to applications that demonstrate the involvement and support of community-based stakeholders and other end-users (e.g., clinicians, patients, parents, public health professionals, patient representatives) along the research continuum.

Individuals from diverse backgrounds, including those from groups historically underrepresented in the STEM fields, who wish to pursue further studies or careers in data science as it relates to addiction research are highly encouraged to apply.

NIDA is interested in applications that leverage data science to advance translation of science to inform drug misuse epidemiology and etiology that can lead to actionable insights. Of particular interest are projects that explore methods, approaches, and/or tools to facilitate the availability, accuracy, and timeliness of data sources that could provide novel insights into substance use prevention and treatment near real-time or real-time, and projects that propose to develop methods and tools for small area estimation to inform decisions of local (e.g., substate) jurisdictions.

This notice applies to due dates on or after June 5, 2022 and subsequent receipt dates through September 8, 2025.

NOT-DA-23-006